摘要
长期系统应用糖皮质激素和免疫抑制剂治疗重度特应性皮炎副作用较大,生物制剂具有更高的安全性,本文就近年来生物制剂治疗重度特应性皮炎的研究进展作一综述。
There are a lot of adverse effects of glucocorticoid and immunosuppressants in the treatment of moderate to severe atopic dermatitis( AD). Biological agents are more safe. The update of the biological agents in the treatment of AD is reviewed in this paper.
出处
《中国麻风皮肤病杂志》
2017年第12期748-751,762,共5页
China Journal of Leprosy and Skin Diseases
关键词
特应性皮炎
生物制剂
atopic dermatitis
biological treatment